EcuaLink: Mitos y realidades sobre el VIH y el SIDA
En materia de salud sexual y reproductiva, la falta de información es tan peligrosa como la abundancia de informaciones erróneas. Ello afecta especialmente al VIH (Virus de Inmunodeficiencia Humana) y al SIDA (Síndrome de Inmunodeficiencia Adquirida), en torno a los cuales giran gran cantidad de concepciones erróneas y mitos que solo contribuyen a aumentar la estigmatización de la afección y descuidar la toma de medidas preventivas.
La profilaxis post-exposición, última barrera para evitar la infección por VIH tras un contacto de riesgo
Un ensayo clínico con 255 pacientes muestra que aquellos individuos que se sometieron a un tratamiento preventivo no contrajeron el VIH, cuando el promedio de contagio tras un contacto de riesgo es del 1%.
Capacitar a las mujeres para que puedan protegerse: promoviendo el preservativo femenino en Zimbabwe
Cuando el SIDA emergió en los años 80 afectaba principalmente a los hombres. Hoy, según las cifras de ONUSIDA, las mujeres representan cerca de la mitad de las 33 millones de personas que viven con el VIH en todo el mundo, y el 60% de las personas infectadas en África subsahariana. La mayoría de estas mujeres se infectaron por el virus manteniendo relaciones heterosexuales, en muchas ocasiones, al practicar sexo sin protección con sus esposos o parejas estables.
“Las mujeres piensan que el matrimonio es un refugio seguro”, afirma Beauty Nyamwanza, del Consejo Nacional de Sida de Zimbabwe. “Creen que cuando alguien se casa no necesita preocuparse por el VIH”.
The state of AIDS in Africa today
The year 2011 concluded with the convening of the International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA) in Addis Ababa, Ethiopia.
This was where medical experts and health officials from all parts of the continent and some international players like former President George Bush (whose administration launched the PEPFAR initiative) took stock of the state of the “War Against AIDS”.
The annual event is described as “opportunity for dialogue and exchange among scientists, communities, people living with HIV, leaders and development partners about recent developments and research findings in prevention, treatment, care and support and to distil their implications for dealing with the AIDS epidemic in Africa”.
The year’s theme was “Own, Scale Up, Sustain” referring to individual African nation’s AIDS efforts.
One prominent speaker is known for his interest in Swaziland’s AIDS situation. Dr. Stephen Lewis is now co-director of the Canadian-based organisation, AIDS-Free World.
At the ICASA conference, he roundly condemned the suspension of new Global Fund Grants, which will certainly hinder progress against AIDS in Swaziland, as “unconscionable, indefensible, and outrageous. It’s murder. And the donor countries expect to get away with it because there is a culture of fiscal impunity”.
He called upon African leaders to address the Global Fund directly and demand that AIDS funding not be interrupted. Lewis, who is Canadian, was quite militant in his comments and insisted that the developed world “owes” Africa financial assistance to combat AIDS, given the developed world’s historic exploitation of the continent, in his view.
Dr. Michel Sidibe, the Executive Director of UNAIDS was also critical of the Global Fund’s decision to halt future grants until at least 2014.Medicins san Frontiers (MSF) released the results of its survey of nine sub-Saharan African countries which found that a majority of these countries had to suspend or reduce health programmes, including an upscale of their ARVs rollout campaigns. The reasons were all the same: lack of funding.
Back in 2001, all African countries committed themselves to government spending on public health that is the equivalent of 15% of their government budgets. At the ICASA meeting it was revealed that a decade later only six countries – Rwanda, Botswana, Niger, Burkina Faso, Zambia and Malawi – are in fact spending this amount on health care for their peoples.
Even these six countries have to rely on international donor funding to provide services, and if left to their own resources would not be able to achieve the target.
Officials at the ICASA conference argued that the money to fight AIDS exists in government budgets, but it is being channelled to other uses. They called for “new priorities” in government spending.
Swaziland is certainly not alone in its funding needs. In fact, throughout Africa 85% of HIV and AIDS funding comes from international donors. Only a much smaller fraction (15%) of AIDS funding comes from African countries themselves.
The Kaiser Family Foundation released its 2011 survey of international funding on health care, and the report documented a significant drop of 10% international funding for AIDS programmes in developing countries.
The Kaiser survey concluded; “Now many African countries are facing the real threat of not meeting their budget requirements for implementing the much needed scale up of ART programmes, relying heavily on the Global Fund and PEPFAR to sustain these programmes”.
No wonder the Global Fund crisis is being described as a “wake up call” aimed at rousing officials into action. What is needed is for Swaziland and all other African countries to develop and sustain an HIV/AIDS funding strategy that is not hostage to external “shocks” like the Global Fund grants suspension.
The ICASA conference looked ahead to a future which is much like the present: no AIDS vaccine yet developed and thus a sustained need for mitigation and treatment programmes like those ongoing today.
Between now and 2032, the worldwide cost of AIDS will be about twice what is currently spent on the disease. In Africa, where AIDS is most prevalent amongst the general population, the cost of AIDS will more than double.
Officials like UNAIDS’ Sidibe referred to the funding crisis and AIDS efforts as being at a break or make point. “Of all the parts of the world where the global funding crisis hasan impact, Africa’s (AIDS) crisis would be most affected,” he said.
The conference conclusion had implication for the way the AIDS battle will play out in 2012 and beyond: International funding may not soon return and so it is imperative that African countries devise new funding strategies aimed inward, to local resources and re-examine all other manner of government spending that is not directed toward an epidemic that is sabotaging the health of their people’s health and the performance of their countries’ economies.
Fuente: Swazi Observer
Guìas Para Tener Relaciones Sexuales Más Seguras
La infección con el VIH puede ocurrir durante las actividades sexuales. Las relaciones sexuales no son de riesgo si no hay VIH presente, no hay sangre ni fluidos sexuales o si no existe manera de que el VIH ingrese al cuerpo. Usted puede reducir el riesgo de infección si evita actividades poco seguras o si usa barreras como condones. Decida cuáles son sus límites y cúmplalos.
Gay men having unprotected sex think that having HIV is still a big deal, but that it’s now harder to transmit
A study of Australian gay men examining unprotected sex and the beliefs that are associated with it has found that the concept of ‘treatments optimism’ needs to be unpacked. While some men do think that having HIV is less serious than it used to be, there is more of an association between unprotected sex and men believing that treatments have made HIV-positive people less infectious.
México reporta más de 149 mil casos de VIH/SIDA
La epidemia de SIDA en México, continúa concentrada con una prevalencia de hombres y mujeres entre los 15 y 49 años de edad, es decir, el 0.37 por ciento del total de los casos, pese a que México se ubica en los niveles más bajos del mundo.
Las infecciones sexuales podrían detectarse con el olfato
Según estudio ruso, las enfermedades de transmisión sexual producirían un olor desagradable en el sudor de los hombres que las padecen.
Cómo afecta al VIH el uso de drogas recreativas
El uso de drogas para recreación aumenta las posibilidades de que una persona se infecte con el VIH. Además, en las personas que toman antirretrovirales (ARV) para combatir el VIH, puede haber interacciones graves entre las drogas y los medicamentos ARV. Estas interacciones pueden llevar a una dosis insuficiente o a una sobredosis de los ARV o de las drogas recreativas. Algunas de estas interacciones pueden ser mortales.
